Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD–ACE2 complexes in living cells by competitive binding

Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD–ACE2 complexes in living cells by competitive binding

Bibliographic Details
Main Authors:	Lu Miao, Wei Zhou, Chunyu Yan, Yuebin Zhang, Qinglong Qiao, Xuelian Zhou, Yingzhu Chen, Guangying Wang, Zhendong Guo, Jun Liu, Hailong Piao, Xia Pan, Mengxue Yan, Weijie Zhao, Guohui Li, Yueqing Li, Zhaochao Xu
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	SARS-CoV-2 RBD–ACE2 interaction Inhibitors screening Live-cell imaging
Online Access:	http://www.sciencedirect.com/science/article/pii/S221138352200257X

Similar Items

АНАЛИЗ ВЛИЯНИЯ МУТАЦИЙ НА АФФИННОСТЬ СВЯЗЫВАНИЯ В КОМПЛЕКСАХ ACE2 И RBD S-БЕЛКА КОРОНАВИРУСОВ
by: Богданова Е.А., et al.
Published: (2023-11-01)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
by: Abdullah Hoter, et al.
Published: (2022-05-01)

Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD/ACE2 binding site
by: Michela Buonocore, et al.
Published: (2022-11-01)

A Suitable Membrane Distance Regulated by the RBD_ACE2 Interaction is Critical for SARS‐CoV‐2 Spike‐Mediated Viral Invasion
by: Mengdan Wu, et al.
Published: (2023-10-01)

Computational design of medicinal compounds to inhibit RBD-hACE2 interaction in the Omicron variant: unveiling a vulnerable target site
by: Muhammad Shahab, et al.
Published: (2023-01-01)

Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2
by: Xi Chen, et al.
Published: (2022-08-01)

Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein
by: Lingbing Zhang, et al.
Published: (2022-06-01)

Molecular docking study and mapping the binding site of some antiviral nanobodies against receptor binding domain (RBD) of SARS-COV 2
by: zahra pahlavan, et al.
Published: (2021-06-01)

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
by: Ming-Feng He, et al.
Published: (2022-10-01)

Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor
by: Arun Bahadur Gurung, et al.
Published: (2022-02-01)

Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
by: Arun Bahadur Gurung, et al.
Published: (2021-02-01)

Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2
by: Ariana Ghez Farrell, et al.
Published: (2022-09-01)

Exploring the Interaction between Vancomycin/Teicoplanin and Receptor Binding Domain (RBD) of SARS-CoV-2
by: Wen-Tao Tao, et al.
Published: (2021-01-01)

Evaluating the Spike–hACE2 interactions in the wild type and variants of concern of SARS -CoV-2 at different temperatures
by: Nabanita Mandal, et al.
Published: (2024-01-01)

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
by: Jeroen Pollet, et al.
Published: (2021-08-01)

The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
by: Valentin A. Semenov, et al.
Published: (2022-12-01)

A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2
by: Xiaoning Wang, et al.
Published: (2021-02-01)

Xeno-Nucleic Acid (XNA) 2’-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding
by: Irani Alves Ferreira-Bravo, et al.
Published: (2021-10-01)

Inhibitors of the RBD-ACE-2 Found among a Wide Range of Dyes by the Immunoassay Method
by: Ekaterina D. Mordvinova, et al.
Published: (2023-02-01)

Studying the Effect of Glycosylation towards SARS-CoV-2 Spike RBD and ACE2 Interaction by Native Mass Spectrometry
by: LUO Yu-xiang;HUANG Jing;LI Hui-lin
Published: (2022-11-01)

SARS-CoV-2 tetrameric RBD protein blocks viral infection and induces potent neutralizing antibody response
by: Zheng Liu, et al.
Published: (2022-10-01)

Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model
by: Balkrishna A, et al.
Published: (2021-03-01)

Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
by: Jiacheng Xiong, et al.
Published: (2021-09-01)

Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness via HSPGs: A review and mechanistic hypothesis
by: Zhongyun Zhang, et al.
Published: (2022-08-01)

Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
by: Ashlesha Deshpande, et al.
Published: (2021-06-01)

Coronil effectively inhibits the interaction of clinically relevant Omicron mutants of SARS-CoV-2 spike proteins with human ACE2 receptor
by: Acharya Balkrishna, et al.
Published: (2025-02-01)

Structural basis of increased binding affinities of spikes from SARS-CoV-2 Omicron variants to rabbit and hare ACE2s reveals the expanding host tendency
by: Kaiyuan Shi, et al.
Published: (2024-02-01)

A Bioluminescent Biosensor for Quantifying the Interaction of SARS-CoV-2 and Its Receptor ACE2 in Cells and In Vitro
by: Xiaolong Yang, et al.
Published: (2021-06-01)

In-silico study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2
by: Jeffry Medina-Barandica, et al.
Published: (2023-01-01)

Identification of Surface Glycoprotein Mutations of SARS-CoV-2 in Isolated Strains from Iraq
by: Ali A. Dawood, et al.
Published: (2022-07-01)

Aspects of the physiochemical properties of SARS-CoV-2 to prevent S-protein receptor binding using Arabic gum
by: Ghobashy Mohamed Mohamady, et al.
Published: (2022-02-01)

SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility
by: Mariana Valério, et al.
Published: (2022-10-01)

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
by: Federico Bertoglio, et al.
Published: (2021-07-01)

Development of an RBD-Fc fusion vaccine for COVID-19
by: Yisheng Sun, et al.
Published: (2024-01-01)

Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19
by: Thi Nhu Mai Tran, et al.
Published: (2021-12-01)

Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction
by: Sara M. Villada-Troncoso, et al.
Published: (2024-09-01)

Antibodies and Vaccines Target RBD of SARS-CoV-2
by: Long Min, et al.
Published: (2021-04-01)

RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
by: Ting Y. Wong, et al.
Published: (2022-08-01)

Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2Research in context
by: Annarita Miluzio, et al.
Published: (2023-01-01)

Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBD
by: Denis E. Kolesov, et al.
Published: (2022-02-01)